1205 KIMBALL BLVD., JASPER, IN
Reports Q4 Results; Provides Guidance for Fiscal 2027 Highlighted by Organic Sales Growth and Accretive Impact of the Helvoet Acquisition
Acquires European-Based Medical CDMO, Helvoet Polymer Technologies B.V.
Reports Q3 Results With Double-Digit Sequential Medical Sales Growth; Affirms Guidance For Fiscal 2026 With Adjusted Operating Margin Expected At High End Of Range
Releases 2025 Annual Sustainability Report
Reports Q2 Results; With Strong Sales Growth in the Medical Vertical; Raises Its Guidance for Fiscal 2026
Announces Date for Ribbon-Cutting Ceremony at New Medical Manufacturing Facility in Indianapolis
Shareholders Reelect Class II Directors at Annual Meeting
Reports Q1 Results; Reiterates Guidance for Fiscal 2026
FY 2025
Q3
Q2
Q1
FY 2024
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Specialized Disclosure Report
Annual Report of Employee Stock Purchase Transition